angiotensin ii has been researched along with Osteolysis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuohashish, HM; Ahmed, MM; Al-Rejaie, SS; Khattab, MM; Sabry, D | 1 |
1 other study(ies) available for angiotensin ii and Osteolysis
| Article | Year |
|---|---|
ACE-2/Ang1-7/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats.
Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Captopril; Delayed-Action Preparations; Female; Femur; Humans; Osteolysis; Osteoporosis, Postmenopausal; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Spectrophotometry, Atomic; X-Ray Microtomography | 2017 |